Dr. Venkatesh Segu has over 19 years of clinical experience in Endocrinology, Diabetes, and Internal Medicine. He has been formally trained in both the U.S. and India and has actively contributed to a variety of research publications. He is passionate about dedicating time to patients so they can get the best medical care possible.
After practicing in Texas, Indiana, and Utah, Dr. Segu founded Capital Endocrine & Diabetes in 2011 with the intent of providing dedicated, personalized medical services to his patients.
Dr. Segu lives with his wife in Austin, TX, and has a son, daughter, puppy and parrot. He also enjoys watching basketball, football, and tennis.
Segu VB, Mahvi DM, Wilson MA, Hale SJ, Warner TF, Meredith M, Shenker Y. Use of In-111 pentetreotide scintigraphy in the diagnosis of a midgut carcinoid causing Cushing's syndrome. European Journal of Endocrinology 137(1):79-83, 1997.
Segu VB, Guodong Li, Stewart A Metz. Use of a soluble tetrazolium compound to assay metabolic activation of intact ß cells. Metabolism 47 (7): 824-830, 1998.
Guodong Li, Segu VB, Rabaglia ME, Luo R, Kowluru A, Metz SA. Prolonged depletion of GTP induces death of insulin-secreting cells by apoptosis. Endocrinology 139:3752-3762, 1998.
Kowluru A, Li GD, Rabaglia ME, Segu VB, Hofmann F, Aktories K, Metz SA. Evidence for differential roles of the Rho subfamily of GTP-binding proteins in glucose-and calcium-induced secretion from pancreatic beta cells. Biochemical Pharmacology 54 (10): 1097‑1108, 1997 Nov 15.
Briaud I, Harmon JS, Kelpe CL, Segu VB, Poitout V. Lipotoxicity of the pancreatic ß cell is associated with glucose-dependent esterification of fatty acids into neutral lipids. Diabetes 50 (2): 315-21, 2001.
Metz S, Holland S, Johnson L, Espling E, Rabaglia M, Segu VB, Brockenbrough S, Tran PO. Inosine-5’-monophosphate dehydrogenase is required for mitogenic competence of transformed pancreatic beta cells. Endocrinology 142 (1): 193-204, 2001.